Fmoc-Gln(Trt)-OH
Suppliers
Names
[ CAS No. ]:
132327-80-1
[ Name ]:
Fmoc-Gln(Trt)-OH
[Synonym ]:
N-Fmoc-N'-trityl-L-glutamine
Fmoc-Gln(Tr)-OH
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-trityl-L-glutamine
MFCD00077056
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoic acid
Nalpha-Fmoc-Ndelta-Trityl-L-Glutamine
fmoc-Gln(Trt)-OH
Fmoc-L-Gln(Trt)-OH
N-Fmoc-N5-trityl-L-Glutamine
L-Glutamine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-(triphenylmethyl)-
N|A-Fmoc-N|A-trityl-L-glutamine
Fmoc-Gln(N-Trt)-OH
Chemical & Physical Properties
[ Density]:
1.3±0.1 g/cm3
[ Boiling Point ]:
873.5±65.0 °C at 760 mmHg
[ Melting Point ]:
165-172 °C
[ Molecular Formula ]:
C39H34N2O5
[ Molecular Weight ]:
610.70
[ Flash Point ]:
482.1±34.3 °C
[ Exact Mass ]:
610.246765
[ PSA ]:
104.73000
[ LogP ]:
8.09
[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C
[ Index of Refraction ]:
1.636
[ Storage condition ]:
2-8°C
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H317-H413
[ Precautionary Statements ]:
P280
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S22-S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Articles
Biopolymers 104 , 116-27, (2015)
The cancer protein NY-ESO-1 has been shown to be one of the most promising vaccine candidates although little is known about its cellular function. Using a chemical protein strategy, the 180 amino aci...
Sci. Rep. 4 , 6777, (2014)
Amyloid-β (Aβ) is one of the few neuropathological biomarkers associated with transporters of the blood-brain barrier (BBB). Despite the well-characterized clinical indication of decreasing Aβ levels ...
ChemBioChem. 17 , 719-26, (2016)
Serpin proteins irreversibly inhibit serine proteases, but only a small part of the serpin reactive-center loop (RCL) is responsible for the initial protein-protein interaction (PPI). To develop pepti...